FADD at the Crossroads between Cancer and Inflammation

• Autores: Sara Mouasni, Léa Tourneur
• Localización: Trends in immunology, ISSN 1471-4906, Vol. 39, Nº. 12, 2018, págs. 1036-1053
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • Initially described as an adaptor molecule for death receptor (DR)-mediated apoptosis, Fas-associated death domain (FADD) was later implicated in nonapoptotic cellular processes. During the last decade, FADD has been shown to participate and regulate most of the signalosome complexes, including necrosome, FADDosome, innateosome, and inflammasome. Given the role of these signaling complexes, FADD has emerged as a new actor in innate immunity, inflammation, and cancer development. Concomitant to these new roles, a surprising number of mechanisms deemed to regulate FADD functions have been identified, including post-translational modifications of FADD protein and FADD secretion. This review focuses on recent knowledge of the biological roles of FADD, a pleiotropic molecule having multiple partners, and its impact in cancer, innate immunity, and inflammation